17-80082018-A-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_017950.4(CCDC40):c.1949A>G(p.Asn650Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N650T) has been classified as Uncertain significance.
Frequency
Consequence
NM_017950.4 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 15Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autoimmune diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_017950.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC40 | NM_017950.4 | MANE Select | c.1949A>G | p.Asn650Ser | missense | Exon 12 of 20 | NP_060420.2 | ||
| CCDC40 | NM_001243342.2 | c.1949A>G | p.Asn650Ser | missense | Exon 12 of 18 | NP_001230271.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC40 | ENST00000397545.9 | TSL:5 MANE Select | c.1949A>G | p.Asn650Ser | missense | Exon 12 of 20 | ENSP00000380679.4 | ||
| CCDC40 | ENST00000574799.5 | TSL:1 | n.1486A>G | non_coding_transcript_exon | Exon 8 of 16 | ||||
| CCDC40 | ENST00000374877.7 | TSL:5 | c.1949A>G | p.Asn650Ser | missense | Exon 12 of 18 | ENSP00000364011.3 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151254Hom.: 0 Cov.: 26 show subpopulations
GnomAD2 exomes AF: 0.0000364 AC: 9AN: 247332 AF XY: 0.0000298 show subpopulations
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461864Hom.: 0 Cov.: 34 AF XY: 0.0000399 AC XY: 29AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000152 AC: 23AN: 151372Hom.: 0 Cov.: 26 AF XY: 0.000149 AC XY: 11AN XY: 73932 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:3
Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 454881). This variant has not been reported in the literature in individuals affected with CCDC40-related conditions. This variant is present in population databases (rs201064110, gnomAD 0.03%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 650 of the CCDC40 protein (p.Asn650Ser).
The p.N650S variant (also known as c.1949A>G), located in coding exon 12 of the CCDC40 gene, results from an A to G substitution at nucleotide position 1949. The asparagine at codon 650 is replaced by serine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at